2020 Global Company of the Year
VIDA delivers true value to clinicians and clinical trial sponsors by driving efficiency and time savings as well as aiding early detection and better outcomes for lung disease management.
VIDA’s experience and approach follows modern trends, and unlike most of the radiology AI community, is moving towards personalized medicine.
Another example of VIDA’s forward-thinking approach is its determination to take a patient-pathway centric approach.
Get the Report
